HEIH

ncRNA information

ncRNA name

HEIH

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-98-5p/PI3K/AKT

Cancer information

Cancer name

Hepatocellular Carcinoma

Cancer site

qRT-PCR,Western blot,Dual-luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Sorafenib

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway

Tissue resource

hepatocellular carcinoma tissues

hepatocellular carcinoma cell lines HCCLM3

hepatocellular carcinoma cell lines Huh7

Experiment

None


Institute

Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Shanghai Academy of Life Science

Country

China

China

Continent

Asia

Asia